These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 30680887)

  • 1. Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study.
    Sopfe J; Endres A; Campbell K; Hayes K; Trout AT; Liang X; Lorsbach R; O'Brien MM; Cost CR
    Pediatr Blood Cancer; 2019 May; 66(5):e27613. PubMed ID: 30680887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and treatment outcomes of Castleman disease in children: a retrospective cohort in China.
    Hu S; Li Z; Wang H; Chen L; Ma Y; Zhu X; Li J; Dong R; Yao W; Dong C; Zhang H; Li K; Dong K; Zhai X
    Eur J Pediatr; 2023 Dec; 182(12):5519-5530. PubMed ID: 37782352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Herpesvirus Type 8-positive Multicentric Castleman Disease.
    Melikyan AL; Egorova EK; Julhakyan HL; Kovrigina AL; Savchenko VG
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S159-65. PubMed ID: 27133959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.
    Nabel CS; Sameroff S; Shilling D; Alapat D; Ruth JR; Kawano M; Sato Y; Stone K; Spetalen S; Valdivieso F; Feldman MD; Chadburn A; Fosså A; van Rhee F; Lipkin WI; Fajgenbaum DC
    PLoS One; 2019; 14(6):e0218660. PubMed ID: 31242229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological characteristics of Castleman disease: an observational study in a Spanish tertiary hospital.
    González-García A; Patier de la Peña JL; García-Cosio M; Sarhane Y; Sánchez Díaz C; Barbolla Díaz I; López Rodríguez M; Moreno MÁ; Villarubia J; Manzano L
    Leuk Lymphoma; 2019 Dec; 60(14):3442-3448. PubMed ID: 31305183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of Castleman disease.
    Dispenzieri A; Fajgenbaum DC
    Blood; 2020 Apr; 135(16):1353-1364. PubMed ID: 32106302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Castleman Disease: A Multicenter Case Series from Turkey.
    Gündüz E; Kırkızlar HO; Ümit EG; Karaman Gülsaran S; Özkocaman V; Özkalemkaş F; Candar Ö; Elverdi T; Küçükyurt S; Paydaş S; Çeneli Ö; Karakuş S; Maral S; Ekinci Ö; İpek Y; Kis C; Güven ZT; Akdeniz A; Celkan T; Eroğlu Küçükdiler AH; Akgün Çağlıyan G; Özçelik Şengöz C; Karataş A; Bulduk T; Özcan A; Belen Apak FB; Canbolat A; Kartal İ; Ören H; Töret E; Özdemir GN; Bakanay Öztürk ŞM
    Turk J Haematol; 2022 Jun; 39(2):130-135. PubMed ID: 35176839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.
    Nagy A; Bhaduri A; Shahmarvand N; Shahryari J; Zehnder JL; Warnke RA; Mughal T; Ali S; Ohgami RS
    Blood Adv; 2018 Mar; 2(5):481-491. PubMed ID: 29496669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of Castleman disease.
    Soumerai JD; Sohani AR; Abramson JS
    Cancer Control; 2014 Oct; 21(4):266-78. PubMed ID: 25310208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The French paediatric cohort of Castleman disease: a retrospective report of 23 patients.
    Borocco C; Ballot-Schmit C; Ackermann O; Aladjidi N; Delaleu J; Giacobbi-Milet V; Jannier S; Jeziorski E; Maurier F; Perel Y; Piguet C; Oksenhendler E; Koné-Paut I; Galeotti C
    Orphanet J Rare Dis; 2020 Apr; 15(1):95. PubMed ID: 32303241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients.
    Pria AD; Pinato D; Roe J; Naresh K; Nelson M; Bower M
    Blood; 2017 Apr; 129(15):2143-2147. PubMed ID: 28143881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Castleman disease associated with AA amyloidosis: description of 2 new cases and literature review.
    Fayand A; Boutboul D; Galicier L; Kahn JE; Buob D; Boffa JJ; Cez A; Oksenhendler E; Grateau G; Ducharme-Bénard S; Georgin-Lavialle S
    Amyloid; 2019 Dec; 26(4):197-202. PubMed ID: 31364863
    [No Abstract]   [Full Text] [Related]  

  • 13. Comprehensive analysis of 65 patients with Castleman disease in a single center in China.
    Wang XQ; Zhong NN; Sun Q; Yan SC; Xu GC; Wang YG; Peng LW; Liu B; Bu LL
    Sci Rep; 2022 May; 12(1):8694. PubMed ID: 35610300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.
    Yu L; Tu M; Cortes J; Xu-Monette ZY; Miranda RN; Zhang J; Orlowski RZ; Neelapu S; Boddu PC; Akosile MA; Uldrick TS; Yarchoan R; Medeiros LJ; Li Y; Fajgenbaum DC; Young KH
    Blood; 2017 Mar; 129(12):1658-1668. PubMed ID: 28100459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unicentric Castleman Disease.
    Wong RSM
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):65-73. PubMed ID: 29157620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of 30 cases of Castleman disease with different types of thoracic involvement].
    Zhang XX; Jiang L; Wang CY; Gu YY; Li LG; Xia TT; Huang Y; Huang PK; Zhang QL
    Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):149-156. PubMed ID: 32135633
    [No Abstract]   [Full Text] [Related]  

  • 17. T-Cells Subsets in Castleman Disease: Analysis of 28 Cases Including Unicentric, Multicentric and HHV8-Related Clinical Forms.
    Fraticelli S; Lucioni M; Neri G; Marchiori D; Cristinelli C; Merli M; Monaco R; Borra T; Lazzaro A; Uccella S; Arcaini L; Paulli M
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical Features and Prognosis of Patients with Castleman's Disease].
    Huang XJ; Zhang XL; Wei XF; Liang XQ; Fu Y; Zhao YY; Li QF; Zhang QK; Feng YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):135-140. PubMed ID: 36765490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Castleman disease: A single-center case series.
    Pribyl K; Vakayil V; Farooqi N; Arora N; Kreitz B; Ikramuddin S; Linden MA; Harmon J
    Int J Surg Case Rep; 2021 Mar; 80():105650. PubMed ID: 33631648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients.
    Zhang X; Rao H; Xu X; Li Z; Liao B; Wu H; Li M; Tong X; Li J; Cai Q
    Cancer Sci; 2018 Jan; 109(1):199-206. PubMed ID: 29124835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.